-
ALIM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Alimera Sciences (ALIM)
Company Profile
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.90 mm | 10.90 mm | 10.90 mm | 10.90 mm | 10.90 mm | 10.90 mm |
Cash burn (monthly) | 1.15 mm | 658.92 k | 1.12 mm | 963.08 k | (no burn) | 466.33 k |
Cash used (since last report) | 8.07 mm | 4.63 mm | 7.85 mm | 6.76 mm | n/a | 3.27 mm |
Cash remaining | 2.83 mm | 6.27 mm | 3.05 mm | 4.14 mm | n/a | 7.63 mm |
Runway (months of cash) | 2.5 | 9.5 | 2.7 | 4.3 | n/a | 16.4 |
13F holders | Current |
---|---|
Total holders | 54 |
Opened positions | 28 |
Closed positions | 13 |
Increased positions | 11 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 254.36 bn |
Total shares | 57.82 mm |
Total puts | 18.60 k |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
Caligan Partners | 16.84 mm | $93.60 bn |
Velan Capital Investment Management | 13.61 mm | $75.66 bn |
Therapeutics OcuMension | 11.45 mm | $112.21 mm |
Stonepine Capital Management | 3.51 mm | $19.53 bn |
Boothbay Fund Management | 3.20 mm | $17.78 bn |
Altium Capital Management | 2.15 mm | $11.95 bn |
BLK BlackRock | 1.39 mm | $7.70 bn |
Vanguard | 1.18 mm | $6.55 bn |
JPM JPMorgan Chase & Co. | 1.00 mm | $5.58 bn |
Geode Capital Management | 638.40 k | $3.55 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | Adam Morgan | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 4,178,725 | 0.00 | 0 |
16 Sep 24 | Adam Morgan | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 9,429,808 | 0.00 | 0 |
16 Sep 24 | Adam Morgan | Warrants Common Stock | Sale back to company | Dispose D | Yes | No | 2.1 | 800,000 | 1.68 mm | 0 |
16 Sep 24 | Adam Morgan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.99 | 50,000 | 149.50 k | 0 |
16 Sep 24 | Adam Morgan | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.85 | 1,825 | 3.38 k | 0 |
16 Sep 24 | Caligan Partners | Common Stock, par value $0.01 per share ("Common Stock") | Other | Dispose J | Yes | No | 0 | 16,835,154 | 0.00 | 0 |
16 Sep 24 | Caligan Partners | Notional Derivative Agreements (obligation to buy) Common Stock | Other | Dispose J | Yes | No | 0 | 1 | 0.00 | 0 |
16 Sep 24 | Caligan Partners | Warrants Common Stock | Other | Dispose J | Yes | No | 2.1 | 800,000 | 1.68 mm | 0 |
16 Sep 24 | David Holland | Common Stock | Sale back to company | Dispose D | No | No | 0 | 187,756 | 0.00 | 0 |
16 Sep 24 | David Holland | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.51 | 125,000 | 688.75 k | 0 |